{
    "abstract": "Uterine leiomyomas, also known as fibroids or myomas, occur in an estimated 70-80% of reproductive aged women. Many experience debilitating symptoms including pelvic pain, abnormal uterine bleeding (AUB), dyspareunia, dysmenorrhea, and infertility. Current treatment options are limited in preserving fertility, with many opting for sterilizing hysterectomy as a form of treatment. Currently, surgical interventions include hysterectomy, myomectomy, and uterine artery embolization in addition to endometrial ablation to control AUB. Non-surgical hormonal interventions, including GnRH agonists, are connotated with negative side effects and are unacceptable for women desiring fertility. Periostin, a regulatory extra cellular matrix (ECM) protein, has been found to be expressed in various gynecological diseases including leiomyomas. We previously determined that periostin over-expression in immortalized myometrial cells led to the development of a leiomyoma-like cellular phenotype. Periostin is induced by TGF-\u03b2, signals through the PI3K/AKT pathway, induces collagen production, and mediates wound repair and fibrosis, all of which are implicated in leiomyoma pathology. Periostin has been linked to other gynecological diseases including ovarian cancer and endometriosis and is being investigated as pharmacological target for treating ovarian cancer, post-surgical scarring, and numerous other fibrotic conditions. In this review, we provide discussion linking pathological inflammation and wound repair, with a TGF-\u03b2-periostin-collagen signaling in the pathogenesis of leiomyomas, and ultimately the potential of periostin as a druggable target to treat leiomyomas.",
    "authors": [
        {
            "affiliation": "Division of Animal Sciences, University of Missouri, Columbia, MO, 65211, USA.",
            "firstname": "Zahra G",
            "initials": "ZG",
            "lastname": "Kiesler"
        },
        {
            "affiliation": "Department of Obstetrics, Gynecology and Women's Health, University of Missouri, Columbia, MO, 65211, USA.",
            "firstname": "Mark I",
            "initials": "MI",
            "lastname": "Hunter"
        },
        {
            "affiliation": "Division of Animal Sciences, University of Missouri, Columbia, MO, 65211, USA.",
            "firstname": "Ahmed Z",
            "initials": "AZ",
            "lastname": "Balboula"
        },
        {
            "affiliation": "Division of Animal Sciences, University of Missouri, Columbia, MO, 65211, USA. Pattersonama@missouri.edu.\nDepartment of Obstetrics, Gynecology and Women's Health, University of Missouri, Columbia, MO, 65211, USA. Pattersonama@missouri.edu.",
            "firstname": "Amanda L",
            "initials": "AL",
            "lastname": "Patterson"
        }
    ],
    "conclusions": null,
    "copyrights": "\u00a9 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.",
    "doi": "10.1007/s00404-024-07435-z\n10.1067/mob.2003.99\n10.1002/ijgo.13102\n10.1016/j.jpsychores.2014.12.016\n10.1038/nrm3904\n10.1093/humupd/dmx032\n10.1055/s-0030-1251475\n10.1093/humrep/deac183\n10.1007/s00441-015-2324-3\n10.1155/2013/173184\n10.1002/ijgo.12666\n10.1073/pnas.0808188105\n10.1111/1471-0528.14640\n10.1016/j.bpobgyn.2015.12.001\n10.1126/science.1208930\n10.1016/j.fertnstert.2014.06.040\n10.1172/JCI81534\n10.1016/j.fertnstert.2014.06.050\n10.1056/NEJMoa1302736\n10.1023/A:1006914301565\n10.1016/j.fertnstert.2010.12.028\n10.3892/etm.2011.186\n10.1161/01.RES.88.5.458\n10.1186/1479-5876-10-183\n10.1016/j.bbadis.2009.06.004\n10.3390/ijms18112435\n10.1016/j.fertnstert.2009.01.081\n10.1055/s-0030-1251476\n10.3390/cells10050982\n10.1016/j.mce.2011.05.044\n10.1042/bj2940271\n10.1359/jbmr.1999.14.7.1239\n10.1007/s12079-022-00674-2\n10.1007/s00018-013-1494-y\n10.3389/fonc.2018.00225\n10.1186/s12935-022-02714-8\n10.1007/s00018-011-0779-2\n10.3390/cells12010050\n10.5603/GP.2020.0064\n10.1016/j.ygyno.2020.11.026\n10.1002/jcp.28113\n10.3109/09513590.2012.671387\n10.1177/1933719115572481\n10.1155/2016/9842619\n10.1210/en.2017-03018\n10.1007/s43032-022-01128-1\n10.3892/ol.2014.2225\n10.3390/ijms22168483\n10.1016/j.jsbmb.2006.08.006\n10.1016/j.fertnstert.2009.03.100\n10.1210/er.2012-1043\n10.1055/s-0035-1558451\n10.1042/BJ20111996\n10.1097/CM9.0000000000000949\n10.3181/0707-MR-190\n10.1097/AOG.0b013e318183fbab\n10.1093/humupd/dmw023\n10.1016/j.ajog.2016.06.051\n10.1111/jog.13519\n10.1016/j.bpobgyn.2017.10.003\n10.1007/s12079-008-0023-5\n10.1016/j.matbio.2014.04.007\n10.1158/1535-7163.MCT-11-0046\n10.1093/carcin/bgi034\n10.1016/j.ajpath.2016.11.010",
    "journal": "Archives of gynecology and obstetrics",
    "keywords": [
        "Fibrosis",
        "Inflammation",
        "Myometrium",
        "Periostin",
        "Uterine fibroids",
        "Uterine leiomyomas"
    ],
    "methods": null,
    "publication_date": "2024-03-05",
    "pubmed_id": "38441600\n12548202\n31960950\n25725565\n25415508\n29186429\n20414841\n36001050\n26613601\n24163697\n30198563\n19047643\n28296146\n26856931\n21868628\n25108465\n26193636\n25106763\n23738515\n9879665\n8077380\n21215393\n22977499\n11249867\n22943793\n19539753\n11158066\n29194370\n19328471\n20414842\n33922329\n21672608\n8363580\n10404027\n35412260\n24146092\n29946533\n36224629\n21833584\n36611997\n32627156\n33317907\n30633360\n22471299\n25759370\n27034956\n29244110\n36418534\n25013460\n34445194\n17097286\n19464003\n23303565\n26251118\n22257180\n32769490\n18222966\n27466209\n29227004\n29128205\n18642132\n24813586\n21670235\n15731169\n28082119",
    "results": null,
    "title": "Periostin's role in uterine leiomyoma development: a mini-review on the potential periostin poses as a pharmacological intervention for uterine leiomyoma.",
    "xml": "<Element 'PubmedArticle' at 0x788502735760>"
}